Filtros de búsqueda

Lista de obras de Jari Koistinaho

ADAMTS-4 in central nervous system pathologies

artículo científico publicado en 2017

Activation of P2X7 Receptors in Peritoneal and Meningeal Mast Cells Detected by Uptake of Organic Dyes: Possible Purinergic Triggers of Neuroinflammation in Meninges

artículo científico publicado en 2019

Astrocyte alterations in neurodegenerative pathologies and their modeling in human induced pluripotent stem cell platforms

scientific article published on 23 April 2019

Cu(atsm) Attenuates Neuroinflammation

scientific article published on 24 September 2018

Distal occlusion of the middle cerebral artery in mice: are we ready to assess long-term functional outcome?

artículo científico

Does Nrf2 gene transfer facilitate recovery after contusion spinal cord injury?

artículo científico publicado en 2013

Dysfunction of Cellular Proteostasis in Parkinson's Disease

artículo científico publicado en 2019

Generation of a human induced pluripotent stem cell line (LL008 1.4) from a familial Alzheimer's disease patient carrying a double KM670/671NL (Swedish) mutation in APP gene

artículo científico publicado en 2018

Generation of a human induced pluripotent stem cell line from a patient with a rare A673T variant in amyloid precursor protein gene that reduces the risk for Alzheimer's disease

article

HX600, a synthetic agonist for RXR-Nurr1 heterodimer complex, prevents ischemia-induced neuronal damage

artículo científico publicado en 2018

Hypoxia induces microRNA miR-210 in vitro and in vivo ephrin-A3 and neuronal pentraxin 1 are potentially regulated by miR-210.

artículo científico publicado en 2008

Intrahippocampal injection of a lentiviral vector expressing Nrf2 improves spatial learning in a mouse model of Alzheimer's disease

artículo científico publicado en 2009

Loss of Cln5 causes altered neurogenesis in a mouse model of a childhood neurodegenerative disorder.

artículo científico publicado en 2017

Loss of Cln5 leads to altered Gad1 expression and deficits in interneuron development in mice

scientific article published on 01 October 2019

Metabolic alterations in Parkinson's disease astrocytes

artículo científico publicado en 2020

Metabolic and immune dysfunction of glia in neurodegenerative disorders: focus on iPSC models

artículo científico publicado en 2020

NF-E2-related factor 2 activation boosts antioxidant defenses and ameliorates inflammatory and amyloid properties in human Presenilin-1 mutated Alzheimer's disease astrocytes

scientific article published on 31 October 2019

Nrf2 regulates antioxidant gene expression evoked by oxidized phospholipids in endothelial cells and murine arteries in vivo

artículo científico publicado en 2008

Nuclear factor erythroid 2-related factor 2 protects against beta amyloid.

artículo científico publicado en 2008

PPARβ/δ-agonist GW0742 ameliorates dysfunction in fatty acid oxidation in PSEN1ΔE9 astrocytes

scientific article published on 19 November 2018

PSEN1ΔE9, APPswe, and APOE4 Confer Disparate Phenotypes in Human iPSC-Derived Microglia

scientific article published on 12 September 2019

Peripheral Administration of IL-13 Induces Anti-inflammatory Microglial/Macrophage Responses and Provides Neuroprotection in Ischemic Stroke

artículo científico publicado en 2019

Selective ferroptosis vulnerability due to familial Alzheimer's disease presenilin mutations

Sex-specific transcriptional and proteomic signatures in schizophrenia

scientific article published on 02 September 2019

Stable RNA interference: comparison of U6 and H1 promoters in endothelial cells and in mouse brain.

artículo científico publicado en 2006

Temporal Dynamics of Gene Expression During Endothelial Cell Differentiation From Human iPS Cells: A Comparison Study of Signalling Factors and Small Molecules

artículo científico publicado en 2018

The Copper bis(thiosemicarbazone) Complex CuII(atsm) Is Protective Against Cerebral Ischemia Through Modulation of the Inflammatory Milieu

artículo científico publicado en 2017

tPA promotes ADAMTS-4-induced CSPG degradation, thereby enhancing neuroplasticity following spinal cord injury